A hospital-wide preoperative cardiovascular risk assessment algorithm guided by selective biomarker testing reduced cardiology referrals and postoperative troponin monitoring without increasing short-term adverse outcomes in noncardiac surgery, according to a retrospective cohort study published in Perioperative Medicine. The investigation evaluated whether incorporating objective functional capacity assessments and targeted biomarker measurements could optimize preoperative evaluation while avoiding unnecessary specialist consultations and cardiac testing.
Perioperative cardiovascular evaluation has traditionally relied on several clinical algorithms, though recent evidence supports more objective functional-capacity assessment and selective biomarker testing. In response, researchers developed and implemented an updated evidence-based preoperative cardiovascular algorithm tailored for patients undergoing noncardiac surgical procedures. The primary goal was to identify patients at elevated risk for major adverse cardiovascular events and guide appropriate management without overutilizing cardiac testing or specialist consultation.
The retrospective before-and-after cohort study was conducted at a university-affiliated hospital, evaluating a total of 66,695 noncardiac surgical patients across three distinct observational intervals to determine the algorithm’s clinical impact. Baseline care spanned from March 2017 to February 2020 and comprised 34,990 patients managed under previous practice patterns. Investigators compared baseline care against two subsequent post-implementation timeframes: post-implementation period 1, spanning January to December 2021 with 11,606 patients, and post-implementation period 2, spanning January to August 2022 with 20,099 patients.
Under the updated algorithm, clinical risk calculation was combined with functional assessment via the Duke Activity Status Index and selective diagnostic testing for asymptomatic adults. Asymptomatic adults with an estimated perioperative cardiovascular event risk greater than 1% were directed toward selective NT-proBNP measurement or cardiac stress testing. Across the intervention intervals, the hospital evaluated two protocol thresholds, employing an NT-proBNP cutoff of 300 pg/mL in post-implementation period 1 and a threshold of 200 pg/mL in post-implementation period 2.
Primary and secondary study outcomes encompassed preoperative NT-proBNP testing rates, cardiology referrals, postoperative troponin measurement, elevated postoperative troponin or perioperative myocardial injury, 30-day myocardial infarction, and all-cause mortality. Preoperative NT-proBNP testing increased significantly from 220 patients (0.7%) at baseline to 174 patients (1.5%) in post-implementation period 1 and 301 patients (1.6%) in post-implementation period 2, with p < 0.001 for each comparison against the baseline care interval.
Among patients who underwent NT-proBNP testing, the proportion with levels greater than 300 pg/mL did not differ significantly between baseline and period 1, recorded at 42.7% versus 34.5% (p = 0.096). In post-implementation period 2, 31.9% of tested patients exceeded the updated protocol threshold of 200 pg/mL. The authors noted that this targeted approach successfully expanded biomarker testing to identify patients needing evaluation.
Cardiology referrals decreased significantly from 0.7% at baseline to 0.2% in period 1 and 0.5% in period 2 (p < 0.001 for each comparison), representing relative reductions of 76.4% and 34.7%, respectively. Postoperative troponin measurement also decreased from 1,343 patients (3.8%) at baseline to 322 patients (2.8%) in period 1 and 550 patients (2.7%) in period 2 (p < 0.001 for each). Among monitored patients, elevated troponin or perioperative myocardial injury rose from 13.7% to 25.5% in period 1 and 19.8% in period 2 (p < 0.001 for each).
Across all evaluated surgical patients, overall rates of perioperative myocardial injury remained steady at 0.5% at baseline, 0.7% in post-implementation period 1, and 0.5% in post-implementation period 2. Furthermore, 30-day myocardial infarction and overall mortality did not differ across the three study cohorts. The study authors concluded that the evidence-based algorithm successfully increased selective NT-proBNP testing and reduced cardiology referrals and postoperative troponin testing without increasing stress testing or short-term adverse outcomes.
Subject of Research: Preoperative cardiac risk assessment algorithm using NT-proBNP in noncardiac surgery
Article Title: Implementing an NT-proBNP-guided preoperative cardiac risk assessment algorithm in noncardiac surgery: a before-and-after cohort study
Article References: Singh, A., Slawski, B., Lauer, K., Rossi, S., Boxhorn, C., Thorgerson, A., & Pfeifer, K. (2026). Implementing an NT-proBNP-guided preoperative cardiac risk assessment algorithm in noncardiac surgery: a before-and-after cohort study. Perioperative Medicine. https://doi.org/10.1186/s13741-026-00763-5
Image Credits: AI Generated
DOI: 10.1186/s13741-026-00763-5
Keywords: NT-proBNP, preoperative cardiac risk, noncardiac surgery, cardiology referral, postoperative troponin, perioperative myocardial injury, Duke Activity Status Index, clinical risk calculation, biomarker testing, cardiac stress testing, myocardial infarction, 30-day mortality, before-and-after cohort study, perioperative medicine, functional capacity assessment, troponin measurement
News Source: Ophelia Keating. (November 17, 2026). Preoperative Cardiac Risk Algorithm Cuts Referrals Without Increasing Surgical Complications. Scienmag.



